ArticleCancer immunology, immunotherapy : CII2025

Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.

Anna R Bopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.